A small molecule inhibitor of Bcl-2, HA14-1, also inhibits ceramide glucosyltransferase

Biochemical and Biophysical Research Communications

Volumn 433, Issue 2, 2013, Pages 170-174

  Niino, Satomi ^a   Nakamura, Yutaka ^a   Hirabayashi, Yoshio ^b   Nagano Ito, Michiyo ^a   Ichikawa, Shinichi ^a  

^a NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

^b RIKEN BRAIN SCIENCE INSTITUTE   (Japan)

Author keywords

Apoptosis; Bcl 2; Glucosylceramide; Inhibitor

Indexed keywords

6 [(( N 7 NITROBENZ 2 OXA 1,3 DIAZOL 4 YL)AMINO)CAPROYL]SPHINGOSINE; APOPTOSIS INHIBITOR; CERAMIDE DERIVATIVE; CERAMIDE GLUCOSYLTRANSFERASE; CERAMIDE GLUCOSYLTRANSFERASE INHIBITOR; ETHYL 2 AMINO 6 BROMO( 1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID; GLYCOSPHINGOLIPID; HA 141; PROTEIN BCL 2; UNCLASSIFIED DRUG; URIDINE DIPHOSPHATE GLUCOSE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CATALYSIS; CONTROLLED STUDY; ENZYME INHIBITION; IC 50; IN VITRO STUDY; KINETICS; LIPOGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION;

EID: 84877654551     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.052     Document Type: Article

References (17)

1. Basu S., Kaufman B., Roseman S. Enzymatic synthesis of ceramide-glucose and ceramide-lactose by glycosyltransferases from embryonic chick brain. J. Biol. Chem. 1968, 243:5802-5804.
2. Ichikawa S., Hirabayashi Y. Glucosylceramide synthase and glycosphingolipid synthesis. Trends Cell Biol. 1998, 8:198-202.
3. Hannun Y.A. The sphingomyelin cycle and second messenger function of ceramide. J. Biol. Chem. 1994, 269:3125-3128.
4. Komori H., Ichikawa S., Hirabayashi Y., Ito M. Regulation of intracellular ceramide in B16 melanoma cells: biological implication of ceramide glycosylation. J. Biol. Chem. 1999, 274:8981-8987.
5. Aert J.M., Ottenhoff R., Powlson A.S., Grefhorst A., van Eijk M., Dubbelhuis P.F., Kuipers F., Serlie M.J., Wennekes T., Sethi J.K., O'Rahilly S., Overkleeft H.S. Pharmacological inhibition of glucosylceramide synthase enhances insulin sensitivity. Diabetes 2007, 56:1341-1349.
6. Liu Y.Y., Han T.Y., Giuliano A.E., Cabot M.C. Ceramide glucosylation potentiates cellular multidrug resistance. FASEB J. 2001, 15:719-733.
7. Inokuchi J., Radin N.S. Preparation of the active isomer of 1-phenyl-2-decanoylamino-3-morpholino-1-propanol, inhibitor of murine glucocerebrosidase synthetase. J. Lipid Res. 1987, 28:565-571.
8. Platt F.M., Neises G.R., Dwek R.A., Butter T.D. N-butyldeoxynojirimycin is a novel inhibitor of glycolipid biosynthesis. J. Biol. Chem. 1994, 269:8362-8365.
9. Cox T., Lachmann R., Hollak C., Aerts J., van Weely S., Hrebicek M., Platt F., Butters T., Dwek R., Moyses C., Gov D., Zimran A. Novel oral treatment of gaucher's disease with N-butyldeoxynojirimycin (OGT918) to decrease substrate biosynthesis. Lancet 2000, 355:1481-1485.
10. Reed J.C. Mechanisms of apoptosis avoidance in cancer. Curr. Opin. Oncol. 1999, 11:68-75.
11. Wang J.L., Liu D., Zhang Z.J., Shan S., Han X., Srinivasula S.M., Croce C.M., Alnemri E.S., Huang Z. Structure-based discovery of an organic compound that binds Bcl-2 protein and induces apoptosis of tumor cells. Proc. Natl. Acad. Sci. USA 2000, 97:7124-7129.
12. Yu N., Aramini J.M., Germann M.W., Huang Z. Reactions of salicylaldehydes with alkyl cyanoacetates on the surface of solid catalysts: syntheses of 4H-chromene derivatives. Tetrahedron Lett. 2000, 41:6993-6996.
13. Lipsky N.G., Pagano R.E. Intracellular translocation of fluorescent sphingolipids in cultured fibroblasts: endogenously synthesized sphingomyelin and glucocerebroside analogues pass through the golgi apparatus en route to the plasma membrane. J. Cell Biol. 1985, 100:27-34.
14. Ichikawa S., Sakiyama H., Suzuki G., Hidari K.I.-P.J., Hirabayashi Y. Expression cloning of a cDNA for human ceramide glucosyltransferase that catalyzes the first glycosylation step of glycosphingolipid synthesis. Proc. Natl. Acad. Sci. USA 1996, 93:4638-4643.
15. Nishie T., Hikimochi Y., Zama K., Fukusumi Y., Ito M., Yokoyama H., Naruse C., Ito M., Asano M. 4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Glycobiology 2010, 20:1311-1322.
16. Ichikawa S., Nakajo N., Sakiyama H., Hirabayashi Y. A mouse B16 melanoma mutant deficient in glycolipids. Proc. Natl. Acad. Sci. USA 1994, 91:2703-2707.
17. Separovic D., Wang S., Awad Maitah M.Y., Hanada K., Kessel D. Ceramide response post-photodamage is absent after treatment with HA14-1. Biochem. Biophys. Res. Commun. 2006, 345:803-808.